Intellipharmaceutics International Inc. (IPCI)

[toomorrow]

Brean capital meeting is likely for securing debt financing for in house manufacturing, sales and distribution expansion. The Odidi's have been very up front that they are likely to expand the company in this direction rather than give up revenues to meager partnership deals. Look, the ATM is for instant cash when you need it for operations. They now have an established revenue stream with Focalin and NO CFO or CEO in their right mind would not explore debt financing at this point in order to rapidly expand the company without damaging share price through dilution. They could easily attracting 10's of millions of dollars in debt financing now and easily pay it all back very quickly after expanding and taking the next ANDA approvals in house for manufacturing and sales. Rexista in house would make this a billion dollar company on its own.